Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jane K. Anderson"'
Publikováno v:
The Journal for Nurse Practitioners. 15:e139-e141
As nurse practitioners (NPs) gain autonomous prescribing status in more states, their ability to work interprofessionally with pharmacists through collaborative practice agreements will increase. Interprofessional care provided by pharmacists and NPs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a380d88a9ba5196d20959ffbd8634f6
https://doi.org/10.1016/j.nurpra.2019.03.006
https://doi.org/10.1016/j.nurpra.2019.03.006
Publikováno v:
The Journal for Nurse Practitioners. 13:e273-e276
Medication therapy problems, such as incorrect dosing, adverse drug reactions, and decreased adherence, result in harm to patients and increases in costs. In the literature, there are many examples of pharmacist-physician partnerships aimed to optimi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca01b4003a1fdb4c4cd8b00bcde0b1fe
https://doi.org/10.1016/j.nurpra.2017.04.001
https://doi.org/10.1016/j.nurpra.2017.04.001
Autor:
Kylee A. Funk, Shanda L. Demorest, Jane K. Anderson, Austin Wagner, Teddie Potter, Michelle Napral
Publikováno v:
Interdisciplinary Journal of Partnership Studies, Vol 4, Iss 3 (2017)
Climate change is the biggest global health threat of the 21st century (Costello et al., 2009). Temperature shifts caused by greenhouse gases have negative health impacts such as worsening of chronic diseases and increases in vector-borne diseases (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e262196b73e8c1a300748bf747affee4
https://pubs.lib.umn.edu/index.php/ijps/article/view/174
https://pubs.lib.umn.edu/index.php/ijps/article/view/174
Autor:
Di An, M. Davis, Nezam H. Afdhal, Kris V. Kowdley, Eric Lawitz, John M. Vierling, Robert H. Hyland, Stuart C. Gordon, William T. Symonds, David R. Nelson, Jane K Anderson, R. Hindes, David E. Bernstein, Tarek Hassanein, M.M. Berrey, Israel Crespo, Hadas Dvory-Sobol, Ira M. Jacobson, Efsevia Albanis, Michael Demicco
Publikováno v:
Lancet (London, England). 381(9883)
Summary Background The uridine nucleotide analogue sofosbuvir is a selective inhibitor of hepatitis C virus (HCV) NS5B polymerase. We assessed the safety and efficacy of sofosbuvir in combination with pegylated interferon alfa-2a (peginterferon) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57e6894cdf8eddca97e55652cdca2f3e
https://pubmed.ncbi.nlm.nih.gov/23499437
https://pubmed.ncbi.nlm.nih.gov/23499437